Our client is a venture capital investment partnership founded in 2018, specializing in Artificial Intelligence Radiology Imaging and other Emerging Medical Technologies, owned and operated by three managing partners with broad ranging domain expertise. Our client has seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies that are already cash flowing.

Our client’s distinguished Managing Partners’ combined credentials span venture capital investment expertise, domain expertise in radiology including a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead groundbreaking leadership in early-stage company investments in the AI/Imaging/Radiology sector.

Our client has seen high quality sector specific deal flow because these companies want the doctors as investors. In addition to dollars, the doctors provide expertise in the field, data and distribution and sales channels.

Our client has developed a portfolio of investments in emerging AI technologies applied to radiology and imaging. This is not just one acquisition but a ‘pool of deals’ so to speak.

NDA is required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.